Capitalized Software Development Costs (Notes)

6 Months Ended

Jun. 30, 2019

Capitalized Software Development Costs Disclosure [Abstract]

Research, Development, and Computer Software Disclosure [Text Block]

Capitalized Software Development Costs

In accordance with the relevant authoritative accounting literature, the Company has capitalized certain software and product related development costs associated with both the Company’s continuing medical education service offerings, the Company’s development of its property and casualty underwriting insurance data exchange platform servicing the London markets, and mobile applications and software enhancements under development for its EbixCash products. During the six months ended June 30, 2019 and 2018, respectively, the Company capitalized $2.6 million and $2.0 million of such development costs. As of June 30, 2019 and December 31, 2018, a total of $13.1 million and $11.7 million, respectively, of remaining unamortized development costs are reported on the Company’s consolidated balance sheet. During the six months ended June 30, 2019 and 2018, the Company recognized $1.2 million and $1.1 million, respectively, of amortization expense with regards to these capitalized software development costs, which is included in costs of services provided in the Company’s consolidated income statement. The capitalized continuing medical education product costs are being amortized using a three-year to five-year straight-line methodology and certain continuing medical education products costs are immediately expensed. The capitalized software development costs for the property and casualty underwriting insurance data exchange platform are being amortized over a period of five years.